STEAP1 and neoplasm: STEAP1, a six-transmembrane epithelial antigen of the prostate, is highly overexpressed in CRPC and shows minimal expression in normal tissues, making it an attractive therapeutic target [40]. It contributes to tumor progression by promoting cancer cell proliferation, invasion, and metastasis.